MONOPAR THERAPEUTICS (MNPR): Price and Financial Metrics
MNPR Price/Volume Stats
| Current price | $28.54 | 52-week high | $38.50 |
| Prev. close | $30.48 | 52-week low | $1.54 |
| Day low | $26.67 | Volume | 68,400 |
| Day high | $31.95 | Avg. volume | 49,827 |
| 50-day MA | $22.45 | Dividend yield | N/A |
| 200-day MA | $8.92 | Market Cap | 174.15M |
MNPR Stock Price Chart Interactive Chart >
MONOPAR THERAPEUTICS (MNPR) Company Bio
Monopar Therapeutics, Inc. engages in developing orphan oncology drugs. The company was founded by Chandler D. Robinson, Christopher M. Starr and Andrew P. Mazar in December 2014 and is headquartered in Wilmette, IL.
MNPR Price Returns
| 1-mo | 10.53% |
| 3-mo | 516.41% |
| 6-mo | 771.45% |
| 1-year | 1,512.43% |
| 3-year | 103.13% |
| 5-year | -65.66% |
| YTD | 29.73% |
| 2024 | 1,193.36% |
| 2023 | -85.65% |
| 2022 | -26.17% |
| 2021 | -47.55% |
| 2020 | -63.13% |
Loading social stream, please wait...